Inspirata Announces ‘End-of-Support’ for Omnyx VL4 and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
141
Inspirata Announces ‘End-of-Support’ for Omnyx VL4 and VL120 Digital Pathology Whole Slide Image Scanners Effective May 4, 2019

Tampa, FL, May 11, 2018 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata ® , Inc. announced today that it has provided 12-month notice officially ending support of the Omnyx® VL4 and VL120 whole slide image scanners. The “End-of-Support” notice provided to customers is effective May 4, 2019. Production of these scanners began in 2013 and ended in 2016.

“The VL4 and VL120 scanners are outdated technology,” says Inspirata CEO Satish Sanan, “so we are working with existing Omnyx customers on a case-by-case basis to move them to our state-of-the-art digital pathology software and workflow solutions and assist them in selecting the most appropriate next-generation scanners based on their specific use cases.

“We are a scanner-agnostic digital pathology software and workflow solutions company, and are wholly focused on digital pathology adoption by developing, implementing and supporting innovative software that enhances the pathology workflow,” continues Sanan. “Our software development teams in Tampa, Pittsburgh and Bangalore, India are busy working on combining the best features of our Digital Pathology Cockpit and the Omnyx Dynamyx software platform so that we can offer customers a converged state-of-the-art technology stack and best-in-class digital pathology workflow solution within a year.”

Omnyx originally introduced the Integrated Digital Pathology (IDP) System VL4 and VL120 Scanners in 2013 but did not refresh the technology thereafter, instead focusing on bringing digital pathology software to pathology departments around the world. The company’s flagship digital software product, Dynamyx , enhances the pathology workflow through collaboration and other tools that boost pathologists’ efficiency. The software is CE-marked in Europe and licensed by Health Canada for in vitro diagnostic (IVD) use.

About Inspirata, Inc.

Inspirata ® , Inc. offers the most comprehensive cancer diagnostics workflow solution available for precision diagnosis today. The solution, which employs a unique “solution-as-a-service” business and delivery model, accelerates anatomic and molecular pathology workflows and facilitates whole slide imaging and image analytics, prognostic and predictive assays, remote consultations and tumor boards. This comprehensive solution includes an Enterprise Service Bus (ESB) to help to solve interoperability issues and a Natural Language Processing Engine (NLP) for structuring data. Inspirata amalgamates this structured data into a central multi-institutional and multi-modal big data cancer repository for clinical, research and educational purposes. Its use will extend to physicians, patients, researchers and pharma among others. This comprehensive solution facilitates a modern precision diagnosis to build a strong foundation for precision medicine. For more information, please visit www.inspirata.com or contact info@inspirata.com .

Marjorie Bulone Inspirata, Inc. 813-570-8905 mbulone@inspirata.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Ice Mobility's Strategic Shift: Partnering with Verizon for Growth

Updated Category News Views 198

Ice Mobility Partners with Verizon for Accessory Distribution Ice Mobility has taken a significant step forward in its journey by announcing a strategic partnership with Verizon, designed to enhance its accessory distribution capabilities. This collaboration not only signifies a crucial milestone but also marks the commencement of a brand refresh that includes an updated...

Continue Reading
China's Lending Rates Expected to Remain Steady Amid Challenges

Updated Category News Views 240

China's Lending Rates Analysis In recent assessments, analysts predict that China is likely to maintain its benchmark lending rates. This expectation is shaped by economic factors such as plummeting yields, shrinking net interest margins, and a depreciating yuan, all of which act as limitations against immediate monetary easing. Economic Factors Influencing the Rates...

Continue Reading
Exciting Updates from Radware Ahead of First Quarter Earnings

Updated Category News Views 190

Radware's Upcoming Earnings Call Announcement As a prominent player in the application security arena, Radware (NASDAQ: RDWR) is set to announce its first quarter results, creating anticipation among investors and industry analysts alike. The scheduled call will take place on May 7, 2025. This event marks a key moment for Radware as they outline their performance and...

Continue Reading
Panera Bread Unveils Unique Croissant Toast Sandwiches

Updated Category News Views 467

Revolutionary Croissant Toast Sandwiches at Panera Bread Panera Bread is excited to enhance your dining experience with the introduction of its remarkable Croissant Toast sandwiches. These delicious sandwiches, available for a limited time, showcase an inventive bread made from croissant dough, providing a delightful butteriness and a satisfying crunch. A Fresh Spring...

Continue Reading
Nymbus Welcomes Ed Gross as Visionary Chief Product Officer

Updated Category News Views 447

Nymbus Enhances Leadership with Ed Gross as Chief Product Officer Nymbus, a leading provider of cloud-based financial technology solutions, has announced the appointment of Ed Gross as its Chief Product Officer (CPO). With vast experience in financial services product management, Gross has been instrumental in advancing Nymbus’ user experience and end-to-end design...

Continue Reading